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In recent years, mindfulness-based interventions (MBI) have gained clinical relevance in
the treatment of patients with schizophrenia spectrum disorders (SSDs). High symptom
burden, long durations of hospitalization and high rehospitalization rates demonstrate the
severity and cost-intensity of these disorders. MBIs have shown promising treatment
outcomes in a small number of trials, primarily taking place in English-speaking countries.
The current study aims to explore mechanisms and processes as well as adverse effects
of MBIs on in-patients with SSDs in a German university hospital setting. A qualitative
design based on inductive thematic analysis accompanied by quantitative assessments
was chosen. A semi-structured interview guide was developed by psychiatrists and
psychologists to assess patient experiences, perceptions, thoughts, and feelings during
and after taking part in a MBI. Twenty-seven interviews were conducted between
September 2017 and October 2018 with in-patients who are diagnosed with
schizophrenia or schizoaffective disorder. Rater-based questionnaires, such as the
Positive and Negative Syndrome Scale (PANSS), Montgomery Asberg Depression
Rating Scale (MADRS), and Psychotic Symptom Rating Scales-Auditory Hallucination
(PSYRATS-AH) were administered at baseline to collect clinical outcomes. Qualitative
analysis revealed two domains: content and function. In the first domain related to content
with the core elements “detachment and rumination”, “presence and getting lost”, “non-
judgment and judgment”, and effects with “emotions”, “cognition”, and “symptom
changes”. A second domain related to function was extracted, including the relevance
of perception of context and transfer to everyday life. Overall, improvements concerning
cognition, distress, and psychopathology were detected, while no adverse effects, such
as increased psychotic symptoms, were revealed. As the first study of its kind,
mechanisms, processes, and the safety of MBIs were explored and confirmed in a
sample of German in-patients with SSDs. The results of this qualitative study are in lineg June 2020 | Volume 11 | Article 6001
Böge et al. Mindfulness for Schizophrenia Spectrum Disorders
Frontiers in Psychiatry | www.frontiersin.orwith recent findings on MBIs amongst patients with psychotic disorders from other
countries. Results lay the ground for future research to focus on the systematic study of
MBIs in large samples, its treatment processes, outcomes, and effectiveness for in-
patients with SSDs.Keywords: mindfulness, schizophrenia spectrum disorders, in-patient, qualitative research, positive symptoms,
negative symptomsINTRODUCTION
In Germany, schizophrenia spectrum disorders (SSDs),
including schizophrenia and schizoaffective disorder, account
for up to 13% of patients in psychiatric hospitals (1). SSDs are
defined by the presence of a broad range of symptoms (2), which
often require expensive and lengthy in- and outpatient
treatment. Symptoms representation is multi-faceted and can
primarily be distinguished along with three main domains (3, 4):
(1) positive symptoms, which are exemplified by delusions,
hallucinations as well as disorganized thinking and behavior
(2, 3); (2) negative symptoms, which are signified by a
diminished emotional expression, anhedonia, blunted affect
and scarcity of speech (4); and finally (3) there is profound
evidence suggesting that SSDs can be characterized by a broad
range of cognitive impairments (5, 6). Cognitive deficits are
experienced through executive dysfunctions in processing speed,
a decrease in attention control, and loss in semantic memory (7).
Moreover, 50% of all affected individuals display comorbid
symptoms of depression (8). It has been estimated that in 65%
of individuals with SSDs, symptoms of anxiety are also present
(9). Therefore, the estimated treatment costs of SSDs for the
German public health system range between 9.63 and 13.52
billion Euros, indicating its cost-intensity (10).
International guidelines recommend evidence-based
treatment options such as psychopharmacology, cognitive-
behavioral therapy (CBT), and psychosocial support for the
treatment of SSDs (11, 12). Several limitations of antipsychotic
pharmacological treatments have been acknowledged (13), as
meta-analyses estimated their effectiveness, primarily measured
on positive symptoms, with overall medium effect sizes (14). The
current state of research highlights the effects of pharmacological
approaches mainly on positive- and depressive symptoms,
although long-lasting improvements on negative symptoms,
cognitive performance, social functioning, and overall quality
of life remain unsatisfactory (14–17). Currently, it has been
assumed that only 29% to 38% of patients achieve full
symptomatic remission within one year (18–20), with
rehospitalization rates of 40% within the first and second year
(21–23). In Germany, the average treatment duration for in-
patients with SSDs is between 21 and 32 days (24).
Furthermore, due to the existing structural, organizational,
and financial barriers, the implementation of professional care,
including psychotherapeutic and psychosocial interventions
during hospitalization and aftercare, has been reported as
insufficient (25, 26). Concerning organizational barriers, it has
been noted that only about 1% of patients with SSDs receivedg 2psychotherapy in Germany (27–29). On a structural level,
national psychotherapy guidelines only covered accessory and
residual symptoms, however, not direct symptoms of SSDs (25,
29). Moreover, insurance companies denied psychotherapy
requests for SSDs more frequently in comparison to other
mental disorders (25). In recent years, however, contextual
changes in favor of psychotherapy for SDD have been
introduced in Germany. The most recent evidence-based
German national guidelines (S3-Leitlinien) (30) have been
amended to now include psychotherapy as a central pillar in
the treatment of SSDs, regardless of illness progression.
Moreover, through comprehensive efforts of multi-stakeholder
treatment options could be partially increased (outpatient
psychotherapy up to 3%) by facilitating state-of-the-art care, anti-
stigma efforts, and training of evidence-based psychotherapy for
SSD to overcome multiple barriers (29). Despite these changes,
there still remains a huge gap in treatment options, therapy
manuals, and well-trained psychotherapists in CBT for SSDs in
both in- and outpatient settings (31, 32). For the in-patient settings,
however, only a minority of patients receive individual CBT in
addition to psychotropic medication due to structural and financial
barriers, whereas group therapies, for instance, metacognitive
training and psychoeducation, are more commonly applied (31,
32). The implementation of individual CBT remains difficult for
SSDs due to prolonged treatment durations and high human
capacity costs (26, 33). Lastly, CBT recommendations are more
frequently based on trials conducted in outpatient settings (34–36),
limiting their practicability and applicability to the direct in-patient
treatment. Since patients with recurrent or chronic psychotic
illnesses spend considerable time in the hospital and outpatient
treatment for relapse-prevention, novel psychotherapeutic
approaches are needed that achieve symptoms reduction and
overall quality of life. Moreover, those interventions should
improve efficiency in short- and long-term treatment by
becoming more economically reasonable and easy to implement
in routine care. Although cognitive-behavioral therapy (CBT), in
combination with pharmacological treatment, is currently the
evidence-based treatment of choice for patients with SSDs, third-
wave cognitive-behavioral approaches are advancing in
psychotherapy research and practice (37, 38), covering domains,
such as mindfulness, acceptance, and cognitive diffusion (39).
The practice of mindfulness is deeply embedded in eastern
meditation traditions. In Buddhist traditions, the term
mindfulness originates in the Pali term sati and can be
translated by bare attention, “keeping faithfully to its post of
observation, watches calmly and without attachment the
unceasing “(40), even though there have been extensive debatesJune 2020 | Volume 11 | Article 600
Böge et al. Mindfulness for Schizophrenia Spectrum Disordersconcerning its broader meaning and application (41). Essentially,
the practice of mindfulness is understood as the presence of spirit
and form - an essential part of Buddhist practice for purifying
consciousness, sharpening wisdom, calmness, and constitutes the
first factor of seven to achieve enlightenment. Mindfulness, as
today's secular and therapeutic exercise in self-awareness has
gained extreme popularity in the Western world in the past
decades. Mainly, due to the work of Kabat-Zinn, who introduced
mindfulness apart from Buddhist religious affiliations into
clinical psychology and psychotherapy. Even though there have
been ongoing debates about the concrete definition and concept
of mindfulness, primarily, it has been defined as a state of clear
consciousness with contentless attention (42). Furthermore, it
involves a non-judgmental moment-by-moment awareness of
thoughts, feelings, and sensations characterized by inner
acceptance. By practicing mindfulness, one is empowered to
increase the awareness of one's own stream of consciousness
from a distant observing point, the meta observer (37). This
practice consequently encourages a mental state depicted by
qualities of nonjudgment, nonreactivity, detachment,
acceptance, and compassion to oneself and among others. In
psychotherapeutic approaches, it is therefore used as a technique
to foster a mindful and accepting stance towards distressing
symptoms and experiences instead of restructuring, changing, or
eradicate these.
In recent years, MBIs have gained substantial scientific
evidence across a range of disorders (43). They have been
endorsed by national clinical guidelines, such as the UK
National Institute for Health and Clinical Excellence (NICE)
and the Canadian Network for Mood and Anxiety Treatments
(CANMAT) for the treatment of affective disorders (44).
Similarly, national guidelines in Germany emphasize MBIs for
the treatment and relapse-prevention of patients with affective
disorders (DGPPN, 2015). Currently, the evidence for
mindfulness-based interventions (MBI) in the treatment of
various psychiatric and somatic disorders is increasing yearly,
including the treatment of other ailments such as chronic pain
(45–47), anxiety (48, 49), depression (50, 51), and eating
disorders (52, 53). Latest research has shown that even short-
termMBIs ranging from one to four sessions can crucially reduce
depressive symptoms and pain sensation (54, 55). Therefore,
MBIs indicate transdiagnostic clinical utility by targeting
individuals' relationship towards symptoms instead of
their remission.
Although MBIs have been used for the treatment of a variety of
mental disorders since the 1970s, research on MBIs in SSDs
remains scarce (56, 57). One reason for this might be the
concern that these interventions could be harmful and cause the
exacerbation of psychotic symptoms (58). Various circumstances
of adapted meditation practices, such as several hours of intensive
meditation, sleep deprivation through meditation, or concentrative
forms of meditation, have been reported to be potentially safe for
patients with SSDs. However, these findings are based mainly on
uncontrolled case studies (59–61). Consequently, research and
clinical trials have deliberately focused on careful adaptations andFrontiers in Psychiatry | www.frontiersin.org 3changes in the implementation of MBIs for patients with SSDs. In
recent years, a small number of randomized controlled trials have
been conducted, showing that adapted MBI protocols can be
successfully, safely, and effectively applied for the treatment of
patients with SSDs. These adaptions comprised the shortening of
mindfulness exercises, minimizing periods of silence, include basic
anchoring exercises, smaller group sizes (< 6), as well as MBIs
delivered by experienced mindfulness practitioners (62). Current
meta-analyses demonstrated that those MBIs protocols are effective
in reducing psychotic symptoms (57) as well as depressive
symptoms in SSDs (57, 63), while results are mixed for negative
symptoms (57, 64–67). Additional studies of MBIs have revealed
an improvement in social functioning (68) and self-esteem (69).
Furthermore, MBIs proved to reduce rehospitalization rates, up to
one-fourth compared to participants that received treatment as
usual (TAU) (68, 70–73). A study also reported shorter in-patient
treatment durations from an average of 18.2 days with TAU to 11.8
days per year in the group with MBIs at an 18-month follow up
(72). Furthermore, a study demonstrated that one year after a brief
four-session MBI, effects remained to be clinically significant (74).
In general, recent research has shown that MBIs have been
successfully applied in group settings and may require less
specialized therapeutic skills or less prolonged professional
training than using CBT in the treatment of patients with
psychotic symptoms. Thus, an implementation is possible in
shorter periods, while significant effectiveness has been shown
within just 6–10 sessions, and patients have shown consistently
high commitment (56, 57, 75, 76). This makes MBIs a cost-
effective treatment option, also potentially suitable for the in-
patient setting, in which frequently only a limited time frame for
psychotherapeutic interventions is available, and group therapies
are commonly implemented. In conclusion, the promising effects
of adapted MBIs in SSDs have been confirmed in four meta-
analyses comprising total psychotic symptoms, positive- as well
as negative symptoms, depression, mindfulness, and
rehospitalization rates and duration (56, 57, 77, 78). Moreover,
two of these explicitly stated that MBIs in group format showed
relatively larger effects compared to individual sessions (57, 78).
The two main mindfulness-based group format protocols
which have been examined so far include the person-based
cognitive therapy protocol designed for community settings in
the UK, and the mindfulness-based psychoeducation protocol
developed and evaluated in Taiwan, Hong Kong, and other parts
of mainland China. Hence, there is a need to consider adopting
their applications to other countries' health systems and cultures.
To the best of the author's knowledge, no manual for German
settings has been developed yet. For an adequate adaptation of
MBIs for the treatment of SSDs, a careful assessment of the
mechanisms and processes of a brief MBI for in-patients in the
German language and health system is imperative. In Germany,
the mental health system displays structural, organizational and
personal differences in comparison with the UK, Hong Kong or
China. While the UK has a strong emphasis on community-
based approaches, in Germany, in-patients with SSD in open
wards tend to be less acute in terms of positive symptoms.June 2020 | Volume 11 | Article 600
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average 37.6 to 40.6 days, in university hospitals up to two-
months are possible) (79). Most wards are open, and patients
stay voluntary. Therefore, German hospitals offer unique
structural settings for psychological interventions such as MBIs
which can successfully be implemented in group format (78).
Concerning the treatment length in Germany MBIs enduring for
approximately four weeks might be especially suitable, even
though an in-patient trial from the UK showed effects after 1–
3 sessions (80).
To this aim, a qualitative approach was selected to achieve an
optimal understanding of the observed clinical outcomes in the
study. Semi-structured interviews were chosen for their
collaborative nature and their capacity to strengthen the
connection between researchers and patients with SSDs (81).
This approach also allows for gaining in-depth insights into the
mechanisms and processes behind MBIs (82). In exploring the
patients' thoughts and perceptions, qualitative research is crucial
to understanding the mental health situation, specific service
needs, and adaptions of MBIs. Therefore, the current study
explores the responses of in-patients with SSDs to adapted
MBIs (62) to understand possible mechanisms and processes
in a German university hospital setting for the first time.METHODS
Design
A qualitative design was chosen with additional quantitative
measures. Initially, rater-based measures were conducted prior to
the group therapy (baseline) in order to assess a variety of clinical
outcomes, including positive-, negative- and depressive
symptoms of SSDs, as well as to examine exclusion criteria.
Furthermore, these quantitative clinical outcomes enabled the
comparability of the present sample characteristics in future
trials and were further used to contextualize results according to
the symptoms representation. However, a priori knowledge did
not inform or alter the analytical process of qualitative data. The
primary focus of the study was on the qualitative assessment of
semi-structured interviews after each therapy session to explore
experiences of psychiatric in-patients with SSDs during and after
MBIs. Thematic inductive analysis (83), also defined as “a
method for identifying, analyzing and reporting patterns
(themes) within data” (84) was chosen for three main reasons:
(1) The processual collecting of data and the intertwined
analytical process, which begins during data collection and in
itself informs the research process, allows a more focalized
approach to issues of mental health (85). (2) Thematic analysis'
well-structured step-wise process of finding, reviewing, and
redefining themes is a transparent, hence reliable and valuable
tool for inductive research in a team. The structured way in
which inductively elicited themes are collated from repeating,
and recurrent patterns in the data additionally allow for
generalized conclusions regarding the effects of MBIs from the
personal experiences and implications of our participants (84,
86). (3) At the same time, direct quotes and detailed descriptionsFrontiers in Psychiatry | www.frontiersin.org 4obtained from the participants provide valuable and valid in-
depth insights into the topic at hand (87, 88).
Procedure
Recruitment took place at the Charité – Universitätsmedizin
Berlin, Department of Psychiatry and Psychotherapy, Campus
Benjamin Franklin. Patients who underwent in-patient or day-
care treatment were asked to participate. Participants fulfilling
inclusion criteria, as shown in Table 1, were offered to attend the
mindfulness-based group therapy (MBGT). Before the first
session, multiple rater-based measures were given to each
consenting participant to verify inclusion criteria and to obtain
current psychopathology severity corresponding to the
international diagnostic criteria based on the ICD-10. After
study participants had attended one or two sessions, the semi-
structured interviews were conducted to collect the qualitative
data. Figure 1 displays the flowchart of the present study.
Participants were informed about the purpose of the study and
written informed consent was obtained. The study was approved
by the ethical committee of Charité – Universitätsmedizin
Berlin, Germany.
Quantitative Questionnaires
Psychotic symptoms were assessed through two dimensions of
the Positive and Negative Syndrome Scale (PANSS) (89), 1) the
Positive Syndrome Scale and 2) the Negative Syndrome Scale.
The PANSS is a widely used and established rating scale to
capture the presence and severity of psychotic symptoms within
the 7 to 14 days before the assessment. Each scale contains seven
items, which can be rated on a scale from 1 to 7, with higher
values representing higher impairment. The Positive Syndrome
Scale contains items about delusions, conceptual disorganization,
hallucinations, excitement, grandiosity, suspiciousness, and
hostility. The Negative Syndrome Scale assesses blunted affect,
emotional withdrawal, poor rapport, passive withdrawal,
difficulty in abstract thinking, lack of spontaneity, and
stereotyped thinking. Scores are obtained by summing items
for each sub-scale separately. In the norm sample of the PANSS,
reported means were 18.2 for the Positive Symptom Scale and
20.0 for the Negative Syndrome Scale (89). Previous research
demonstrated good reliability, predictive validity, and
comparability with the Brief Psychiatric Rating Scale (90).TABLE 1 | Inclusion and exclusion criteria.
Inclusion criteria
• Diagnosed with a schizophrenia spectrum disorder by a qualified psychiatrist
according to ICD-10 criteria
• Informed consent to participate in the study
• Aged between 18 and 65 years
Exclusion criteria
• Severe psychotic symptoms (PANSS, P-Scale any single item > 5)
• Acute suicidality (MADRS, Item 10: Suicidality > 3)
• Acute substance use or substance abuse (except nicotine) according to
ICD-10 criteria
• Severe traumatic cerebral injury in the pastP-Scale, Positive Syndrome Scale of Positive and Negative Syndrome Scale (PANSS).June 2020 | Volume 11 | Article 600
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(91) is a rater-based assessment for the severity of depressive
symptoms in the seven days preceding the assessment. The scale
has ten items that represent the main symptoms in depression
and are sensitive to change. Excellent inter-rater reliabilities
(0.89–0.97) and validity were also shown (91). Every item can
be rated from 0 “no impairment”, to 6 “extreme impairment”.
This results in a total score of 0 to 60, with higher scores
representing the severity of the impairment: 0–6 absent
symptoms, 7–19 mild depression, 20–34 moderate depression,
and > 34 severe depression (92).
If participants were experiencing auditory hallucinations, the
Auditory Hallucinations Rating Scale (AHRS), a subscale taken
from the Psychotic Symptom Rating Scales (PSYRATS-AH; (93)
was conducted. The AHRS is a structured interview assessing
various aspects of acoustic hallucinations such as frequency,
loudness, and length within the past seven days. Psychometric
properties were given with excellent interrater reliability (0.74–
1.00), adequate internal consistency (Kendall's tau-b = 0.63–
0.76), and validity (r = 0.81 with PANSS hallucination item) (94).
Eleven items are rated on five-point scales with individual rating
options. In total, sum scores range between 0 to 55 with higher
scores representing higher impairment.
Intervention
The group was implemented in the patients' health care program as
an add-on to treatment-as-usual (TAU) at the Charité –
Universitätsmedizin Berlin, Campus Benjamin Franklin. At the
hospital, TAU consists of an interdisciplinary approach for in-
patients with SSDs, including psychopharmacological treatment,
psychotherapy (individual therapy and eight group therapies), social
work assistance, occupational therapy, and exercise therapy.
The protocol for mindfulness-based group therapy (MBGT)
(95) was developed through an inductive iterative process.
Various MBI protocols were extracted from the current
literature, carefully adapted for the needs of the patient group,Frontiers in Psychiatry | www.frontiersin.org 5and combined with novel developed exercises. Based on the
interviews, participant experiences were reviewed throughout the
study process. Feedback was analyzed, and in the next step, the
exercises were re-adapted throughout an iterative process until
finally, the SENSE manual emerged (95). The manual describes a
four-week therapy program with three sessions per week, which
were in detail one main session (60 min) and two consolidation
sessions (co-sessions; 30 min). During the development and
through the feedback several adaptions have been conducted
on the protocol including shortening of mindfulness exercises (<
15 min), minimizing periods of silence (< 15 s), basic anchoring
exercises, smaller group sizes (< 6), as well as MBIs delivered by
experienced mindfulness practitioners which are in line with
recommendations of Shonin, Van Gordon, and Griffiths (62).
In the SENSE (mindfulnesS for schizophrENia SpEctrum
disorders) manual, every main session begins with a brief 10-
minute recap of the last week in the context of mindfulness. In a
second step, there is 15-minute interactive psychoeducation on
the main elements of mindfulness (presence in the here-and-
now, non-judgment, and detachment). Third, 10–15 min of
mindfulness exercises are practiced based on the weekly topic
(breathing, detachment, senses in nature, and body awareness).
Lastly, there are 10 min of sharing experiences, based on the
inquiry model (96) as well as 5 min for sharing individual aims
for the next week. Co-sessions repeated the contents and
exercises of the main sessions.
Interviews and Data Collection
A semi-structured interview guide was developed after a
thorough examination and review of the current literature in
the field. Interviewers were instructed to carefully consider the
respondents' state, disclosed by the sample's characteristics as
provided by the quantitative data. The interview questions were
discussed within the research team, consisting of certified
psychiatrists, clinical psychologists, and a sociologist, to assess
their content and ensure the use of simple and precise wording.
At the beginning of each interview, participants were asked to
provide demographic data, such as age, gender, housing
situation, occupation, and first exacerbation of the disorder. A
detailed description of the study process, the interview schedule,
and questions are illustrated in Table 2.
The data was collected between September 2017 and October
2018. Each interview consisted of nine open-ended questions and
lasted between 25 and 45 min in total. The first interviews were
conducted by KB, the principal investigator, who then trained two
researchers (AK and FE) to conduct further interviews; multiple
training sessions were held to ensure consistency. The training
included discussion of the content, clarification of the open-ended
questions, as well as pilot interviews. The interviews were conducted
directly after the group therapy sessions. After the collection of
socio-demographic variables and information on the life situation,
participants were openly asked about their previous knowledge
concerning MBIs as well as their experiences, perceptions, feelings,
thoughts, and symptom perception before, during, and after the
MBIs. The questions gave room for free elaborations about prior
experiences and general knowledge about mindfulness. After
encouraging participants to talk about their experiences, they wereFIGURE 1 | Study flow diagram.June 2020 | Volume 11 | Article 600
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Questions included, for example, “How and/or what did you
perceive during the exercise?” or “What did you perceive in
relation to your mental health during/after the exercise? “to allow
the participants to express their perceptions during the exercise
freely, as well as to explore whether or not there was an exacerbation
of psychotic symptoms. Each participant was interviewed once, at
the latest, after the second session attended. To ensure data safety,
anonymous transcripts were created, and the original interview
documents were kept in locked filing cabinets, to which only the
direct research team had access.
Data Analysis
Following qualitative inductive analysis (86), data was thematically
explored, analyzed, and compared step-wise to identify themes from
the data (83) systematically. First, word-by-word coding (97), as well
as open line-by-line coding (98), was used to reconstruct the data
into keywords and contents and to compare them until concepts
emerged, which allowed for categorization of the data. This fostered
an iterative deepened understanding of the data in a constant critical
and analytical process. In the second step, codes were thematically
categorized into meaningful clusters (84, 99, 100). Finally, these
groups were structurally and conceptually merged, facilitating an
understanding of underlying domains (84, 97). The first two steps
were conducted separately by two trained psychologists and
researchers (AK and EE) using MAXQDA, a software program
designed for computer-assisted qualitative data analysis. The joint
final step integrated the separately found categories by discussing
and relating them. During this stage, an independent qualitative
researcher and sociologist (LF) joined the analysis process to review
the procedure as well as the categorization of the analysis. In a final
step, one psychologist (KB) and psychiatrist (EH) collaborated to
review both content and formal categorization.
Concerning the consolidated criteria for reporting qualitative
research (COREQ) guidelines, the authors acknowledge theirFrontiers in Psychiatry | www.frontiersin.org 6unique background and perspectives to the analyses and aimed to
bring these into consideration (101). The first author (KB) is a male
psychologist, experienced mindfulness trainer (10 years) and a
mindfulness and psychotherapy researcher. The second author
(AK) is a female psychologist, beginning mindfulness trainer and
mindfulness and psychotherapy researcher. The third author (FE) is
a female senior psychiatrist, beginning mindfulness trainer,
psychotherapy researcher. The fourth author (LF) is a male
sociologist and researcher with a strong qualitative background
focusing on mental health advocacy. The fifth author (TT) is a
female senior psychiatrist and psychotherapy researcher with a
strong focus on qualitative and quantitative transcultural
psychotherapy. The sixth author (NT) is a male psychologist and
psychotherapy researcher using qualitative and quantitative
approaches. The seventh author (MB) is a male senior
psychiatrist and psychotherapy researcher. The last author (EH) is
a male senior psychiatrist and psychotherapy researcher. All
discussions aimed to assess any possible influences of these
backgrounds on the analysis process.RESULTS
Quantitative Outcomes
For the current study, 27 participants (22.2% women; 6 women
and 21 men) with a mean age of 35.8 years (SD = 10.9) were
included. Of these, 21 participants were diagnosed with paranoid
schizophrenia and six with schizoaffective disorder. Nineteen
participants were recruited from the ward for psychotic
disorders, while eight participants were from the day-care
ward. All participants were receiving psychotropic medication,
which was not changed relevantly throughout the study process.
Psychopathology assessed by PANSS, MADRS, and PSYRATS-
AH showed that the participants, despite the exclusion of a
severe psychotic episode, had a marked variety of symptoms at
the beginning of the MBIs. On average, participants showed mild
to moderate positive symptoms and moderate negative and mild
depressive symptoms (89). Seven respondents reported
experiencing acoustic hallucinations at the time of the study. A
detailed summary of sample and symptom characteristics is
shown in Table 3.
Qualitative Results
The 27 interviews were conducted and spread out over the
following four sessions: “Mindfulness of breathing” (7),
“Mindfulness of detachment” (7), “Mindfulness of senses in
the context of nature” (6), and “Mindfulness of body
awareness” (7). The thematic analysis of the interview data
reduced the data step-wise, collated initial codes into themes,
which were then redefined in relation to each other. All steps
were conducted not merely by one researcher but by two or
more. Based on the participants' experiences during and after the
sessions, finally, two content and two functional subthemes were
identified throughout the data analysis process. For the content
subthemes, (1) core elements and (2) effects were generated,
referring to essential transdiagnostic elements of mindfulness.TABLE 2 | Study and interview schedule.
Determination of interview ability 5 min
Clarification of open question 5 min
Informed Consent 5 min





1. Do you have any previous experience with this exercise, or does it
remind you of other exercises?
2. What did you notice inside you during the exercise?
3. How would you characterize this exercise?
4. How and what did you perceive during this exercise?
5. What prevented you from doing the exercise, or were there any
difficulties?
6. What did you manage well?
7. Did the exercise affect you anyhow? If so, how?
8. What can you take away for yourself from this exercise, and/or what
did you miss?
9. What did you perceive regarding your symptoms during and after the
exercise?
Time for remarks and comments. 10 minJune 2020 | Volume 11 | Article 600
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transfer to everyday life described the implementation of the
MBGT and participants' transfer of mindfulness associations to
their daily life. Overall, the content domain, therefore, includes
direct content matter and topics (core elements) about
mindfulness as well as the effects on an individual subjective
level. The functional domain, however, covers applicatory
aspects such as the perception of the context, including external
stimuli (therapist's voice, sound bowl, setting). Moreover, this
domain described the practicability to utilize mindfulness in
their everyday life (transfer to everyday life). A summary and
brief description of the categories can be found in Table 4 and
Figure 2.
Content Domain
The content of both subthemes (1) core elements (2) and effects
illustrate participants' experience of and through mindfulness.
All three core elements were found to be coexisting mechanisms
of mindfulness, whereas the effects were described as
consequences of and in relation to the core elements.Frontiers in Psychiatry | www.frontiersin.org 7Core Elements
Participants' responses were found to relate to three core elements
of mindfulness: (1.1) detachment, (1.2) presence, and (1.3) non-
judgment. While detachment and presence were usually named
directly as mechanisms by the interviewees, the latent category
non-judgment was mostly conveyed indirectly through expressed
appreciations. Furthermore, the categories are found to be
dimensional, with a wide range of responses being antagonistic
to each other in participant's perceptions. The dimensionality of
the categories results from the graduations of the participant's
answers, respectively.
Detachment and Rumination. Concerning detachment, it was
found that some participants were able to notice the appearance and
disappearance of their thoughts, sensations as well as emotions:“During the exercise, I noticed again and again that
different thoughts came and then went away again.
(Participant 12; Session: Detachment)
When the stress came up, many thoughts, such as tide
and then slowly the tension, I could put off everything
by the deep inhale and exhale. (Participant 09;
Session: Breathing)”In some instances, participants became aware of internal
processes and were able to differentiate between passive
observations, while others realized a sense of active
engagement with inner processes. While in the first quote,
emotions and thoughts are described passively, from a meta-
observer position (“Came and then go…”), in the second quote,
the participant assigned himself a certain level of agency (“I
could …”).
However, some participants described further processes and
displayed a feeling of identification between themselves and their
psychopathology and the process of de-identification and
de-centering:“So, to realize that they [the symptoms] are only part
of more in me. That I am not always just my
symptoms that I can let go. (…) I am much more
b e s i d e s my s ymp t oms . ( P a r t i c i p an t 1 0 ;
Session: Breathing)”These findings point towards participants' greater self-insight
and self-understanding by detecting differentiated degrees of
association between their psychopathology and self-concepts,
such as self-esteem and recognition of oneself apart from
symptomology. On the other side of the detachment
dimension, participants showed patterns of rumination
illustrated by a narrowed focus on impressions, thoughts, and
emotions. It has been reported that perceived distress is a
common therapeutic problem that prevents participants from
opening themselves to further sensations, such as a change of
perspective (for further discussion of this problem, see 102).“I thought of the past and everything I have already
experienced and been through. (Participant 15,
Session: Body)”TABLE 3 | Characteristics and symptom severity of the participants (n = 27).
M SD Range
Age (years) 35.8 10.9 19–59
Illness duration (years) 10.6 8.9 1–40
Number of episodes 3.5 2.4 1–10
Number of hospitalizations 3.9 2.4 1–10
Length of last hospital stay (days) 78.8 32.1 21–138
PANSS, Positive Syndrome Scale 14.4 5.5 7–24
PANSS, Negative Syndrome Scale 20.4 7.3 7–35
MADRS 14.8 9.1 1–37
AHRS* 21.1 11.7 2–39M, Mean; SD, Standard deviation, *n = 7 participants who reported hearing voices.TABLE 4 | Description of categories.
Content domain
1. Core elements
1.1 Detachment and rumination Attachment to emotions, thoughts,
sensations
1.2 Presence and getting lost Presence in the moment, past or future
1.3 Non-judgment and judgment* Judgement about emotions, thoughts,
sensations
2. Effects
2.1 Emotions Emerged emotions
2.2 Cognition Increased cognition and metacognitive
effects
2.3 Symptom changes Changes in symptoms awareness
Functional domain
3. Perception of Context Awareness of sensory stimulation;
sensing and experiencing contextual
factors (Time, surrounding sounds,
therapists, other group members,
duration)
4. Transfer to everyday life Utility and practicability in daily life*Latent category.June 2020 | Volume 11 | Article 600
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as staying in the here and now, being in the present moment, and
perceiving momentary sensations without actively changing
anything. This can include thoughts, feelings, body sensations, as
well as symptoms. Furthermore, participants described perceiv-
ing through their senses, such as feeling their breath or hearing
noises in nature as a way of being present in the moment which
resulted in changes of perception:Fronti“Sometimes I wonder if everything has gone so well in
the past. Then it helps to sense a feeling, to notice, to
be fresh, to be new, and to be in the here and now.
(Participant 17; Session: Detachment)As I watched my breathing, I automatically changed my
breathing. At first, I thought that was funny, but later I
managed not to change it anymore, but only to perceive it. I
felt better (Participant 07; Session: Nature)”
As shown in the first of the two quotes above, participants
described not only pleasant perceptions, but also the awareness
of negative thoughts and worries, unpleasant body sensations,
emotions, or symptoms. While in those examples, participants
were still able to draw attention to the present moment by
focusing on the breath or another present sensation, others
described how they lost the awareness of the present moment:“I already knew before that the thoughts would
digress. (Participant 10; Session: Breathing)”
“I found it hard to concentrate and started to muse.
(Participant 11; Session: Detachment)”Through the description of concentration problems,
participants' difficulties in keeping awareness at the present
moment were particularly evident. In the sense of a self-
fulfilling prophecy, the participants got lost in ruminations
about their perceived lack in concentration, and thus inhibiting
their contact to the present moment:ers in Psychiatry | www.frontiersin.org 8“I felt time pressure because I did not know how long I
could maintain concentration [ … ]. (Participant 04,
Session: Nature)”Non-Judgement and Judgment. This core element is charac-
terized by the extent of judgment towards perceptions, thoughts,
feelings, and other sensations. Here, some participants describe
their impressions value-free, thus non-judgmentally, and with-
out any categorization:“I perceive my environment and my surroundings
more and differently. I let them affect me more, and
I do not imagine something directly. I try not to judge,
but to perceive. I feel a little more. (Participant 10;
Session: Breathing)”Often, this category was presented only indirectly, through
the description of negative impressions. The participants
reported the appearance of unpleasant sensations, thoughts,
and emotions, but at the same time invalidating the power of
these negative impressions. This indicates that participants did
not judge these negative impressions or had less judgment
about them:“Malaise was noticeable during the exercise but was
not so unpleasant. (Participant 18; Session: Body)”Effects
The category of effects is subdivided into references to (2.1)
emotions, (2.2) cognition, and (2.3) symptom changes. For
example, participants were asked how they perceived the
exercise and which difficulties they had but also about
symptoms they might have perceived during and after the
session. It is noticeable that none of the participants described
negative or adverse effects through the exercise, while
improvements were described frequently.FIGURE 2 | Summary of categories.June 2020 | Volume 11 | Article 600
Böge et al. Mindfulness for Schizophrenia Spectrum DisordersEmotions
Although it was repeatedly stated during the theoretical
conceptualization that mindfulness does not solely pursue the
goal of relaxation or other positive sensations, participants
nevertheless described those positive effects through their
exercises. Asked openly about their perceptions during the
exercises, participants described associations, such as the
feelings of inner peace, relaxation, aliveness, or feeling happiness:Fronti“Joy, peace, freedom, inner peace, relaxation.
(Participant 02; Session: Nature)It has moved something that cannot be put into words. Most
likely ‘inner warmth', ‘authenticity', ‘being with you without
having to do anything about it.' (Participant 07; Session: Nature)”
Cognition
Cognitive effects were described through the reported awareness
of cognitive functioning, self-conceptions, and metacognition. As
mentioned above, participants reported having concentration
difficulties in their daily life. Thus, it was also reported in the
interviews. However, no one described a negative effect on their
concentration or other cognitive functions as a result of the
exercises. Instead, not only an increase in the ability to
concentrate is cited as the most frequent cognitive
improvement (13 of 27 participants reported an increase), but
also stimulation of imagination and creativity, as well as an
increase in self-confidence, were mentioned.
Furthermore, metacognitive insights about their self-concepts
and their functioning were reported:“To have more concentration, because I could follow
the tasks. In the process, I realized that I seem to be
more involved with this than with other [therapy
groups]. (Participant 25; Session: Body)”
“To concentrate completely on me. That went really
well and has promoted my self-confidence. Then, I felt
much more wi th myse l f . (Par t i c ipant 09 ;
Session: Breathing)”Symptom Changes
At the end of every interview, participants were asked to describe
their symptoms before, during, and after the exercise. While
some described an improvement in symptoms, others reported
no observable and subjective changes, however, what is
noteworthy is that no one reported exacerbation or
deterioration of symptoms during or immediately after
the exercises.“Before that, I was very tense and tight. Now I feel
lightness, looseness, and internally flexible.
(Participant 17; Session: Detachment)”
“I feel less stressed. I have felt less anxiety. It's okay
how I am currently. (Participants 19; Session: Body)”
“Everything stayed the same. I do not notice any
difference. The symptoms are actually always theers in Psychiatry | www.frontiersin.org 9same. I just learn more about how to live with them.
(Participant 11; Session: Detachment)”Functional Domain
The two functional subthemes (3) perception of context and (4)
transferability to everyday life refer to the general conditions and
contextual factors as well as participants' direct experience, and
awareness of sensory stimulation emerged through the
intervention. These contain the applicability as well as helpful
or disturbing circumstances for the participants. Frequently,
participants commented on the intervention by emphasizing
the perception of the context of the specific exercises and their
usability in daily life.
Perception of Context
This category emerged through contextual variables, such as the
therapist's voice, the instructions, or the use of a sound bowl as
an anchor stimulus to direct distracted attention back to the
perception in the here and now, which have been frequently
named by participants. Moreover, the duration of the exercise or
the influence and resonance with other group members have
been mentioned. Therewith, participants stated for these factors
an increased awareness of sensory stimulation, which positively
influenced and supported therapeutic processes and mechanisms
described in the previous categories of core elements and effects.“Most of all, I was able to hear the therapist's voice. It
encouraged me to pay more attention to myself and
my inner life. (Participant 26; Session: Breathing)”
“But listening to the therapist's voice helped me. It is
then as an anchor, and you try to focus on it.
(Participant 11; Session: Detachment)”
“The gong was pleasant, relaxing. (Participant 23;
Session: Detachment)”In minor cases, persistent difficulty in carrying out the
exercise was reported (7 out of 27 participants). For the most
part, these were individual difficulties, such as concentration
problems, exhaustion, or hunger. However, sometimes
participants associated difficulties sensing and experiencing
contextual factors, for example, due to disturbing, external
perceptions such as noises from outside, the time of the day
when the session is carried out, or the way exercises
were instructed.“Standing meditation exercise, which was exhausting.
I prefer to sit or lie down. (Participant 22;
Session: Nature)”Transfer to Everyday Life
As the last category, participants reported the desire to transfer
the learned mindfulness associations into the individual everyday
life, demonstrating a vital psychotherapeutic success in the
context of perceived self-efficacy. At the same time,
participants expressed their ideas and visions on how toJune 2020 | Volume 11 | Article 600
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application into their everyday lives.Fronti“You can do this exercise regularly, and it can help you
to cope better with the voices in your head. That's how
you can detach from the voices. (Participant 11;
Session: Detachment)”
“This exercise was much easier to implement [than
Progressive Muscle Relaxation], and that's why I find it
much better. I can do it at home alone. (Participant 13;
Session: Breathing)”
“I was happy to do it. That was a good exercise for
anxiety. I would like to take this as a technique and use
it at work. (Participant 19; Session: Body)”All participants reported having already heard of mindfulness
in some form, or they named related associations from their
everyday lives, even though none of the participants had any
previous experience with MBIs:“A reminder of how I have always sought and found
tranquility and protection while walking through
fie lds and meadows during my psychosis .
(Participant 3; Session: Nature)”DISCUSSION
The main objective of this study was to examine the experiences
of in-patients with SSDs who took part in a brief MBI at a
German university hospital setting. According to the authors'
best knowledge, this is the first account of such a study in
Germany. Collected data across all four different mindfulness
modules were analyzed. Responses generated to a total of four
subthemes within two domains, content and functionality, from
which the effects of the MBIs can be understood. Whereas the
content domain includes references to core elements and effects,
each with three subcategories within the functional domain,
participant awareness of possible transfer to everyday life, and
the perception of context of the intervention is portrayed.
Core Elements of Mindfulness
The first content domain core elements has three subcategories,
including detachment, presence, and non-judgment, which
overlap with key elements of mindfulness practice (42, 45,
103). However, participants' responses suggest that these core
elements should be understood as dimensional categories, each
with two poles along a continuum—detachment and rumination,
presence and getting lost, or non-judgment and judgment. These
polarities are reflected in Chadwick's (102) initially postulated
framework model for patients with SSDs, which distinguishes
between a mindful and distressing reaction to unpleasant
psychotic sensations including voices, paranoid thoughts, or
images. Along these poles, participants, on the one hand, seem
to show a distressing reaction displayed by experimental
avoidance leading to judgments. Therefore, increaseders in Psychiatry | www.frontiersin.org 10rumination and worry occur taking participants back again to
avoidant behavior—reflecting a vicious cycle restraint from
action and getting lost in reaction.
On the other hand, participants learn a mindful response by
allowing unpleasant psychotic experiences to come into
awareness. This is depicted by actively turning towards the
difficult sensations and cultivating acceptance for its current
representation. With practice, individuals learn the process of
letting go and develop more awareness (102). For the current
study, as shown in subcategory 1.1 to 1.3 (Detachment and
Rumination, Presence and Getting Lost, and Non-Judgement
and Judgment), participants' responses seem to verify this
process model and its dimensional categories since the type of
reaction depend on the patients' degree of non-judgmental and
detached awareness on symptom expression in the present
moment. These findings are also consistent with existing
descriptions of the main mechanisms within mindfulness
practice in other clinical groups (96, 103), besides SSDs (102).
For example, for patients with a Major Depressive Episode
(MDE), Mindfulness-based Cognitive Therapy (MBCT) is a
we l l - researched , es tab l i shed , and high ly e ff ec t ive
psychotherapeutic approach. Its underlying theory states that
continuous deterioration of symptoms is experienced through
the repeated associations between dysfunctional mood and
patterns of negative and self-devaluating cognitive processes
(104). In MDE the main aim and core skill that MBCT
provides is the ability to inhibit potential relapses by first
noticing and in a second step disengaging and detaching from
mental states, which are characterized by self-perpetuating
patterns of rumination, negative thoughts, and the tendency to
identify with specific cognitions (105–107).
Moreover, similar treatment mechanisms and process-
variables seem to play a role when implementing MBIs for
patients with SSDs. Participants in the current study highlighted
altered perceptions of the appearance and disappearance of their
thoughts, sensations, and emotions described in subcategory 1.1
(Detachment and Rumination). Furthermore, results seem to
elucidate the effect of MBIs on a behavioral and cognitive level
since the exposure to adverse internal experiences leads to
desensitization and, consequently, symptom decline (45). These
subjective experiences include psychotic experiences, such as
acoustic hallucinations, paranoid thoughts, or images, which
lose their distressing and unpleasant sensation over time when
mindfulness is cultivated by getting in touch with the presence
and perceiving momentary sensations without active engagement.
Overall, these results highlight mindfulness' transdiagnostic effects
as similar, theoretically defined mechanisms seem to be crucial
within the treatment process.Effects of Mindfulness
Three interconnected factors have been extracted from the
interviews demonstrating the effects of mindfulness on
emotion, cognition, and symptom changes. First, participants
stated various effects on their emotional state during and after
the MBI. These included states of deep relaxation, inner peace,
euphoria, and happiness. Since ancient Buddhist times,June 2020 | Volume 11 | Article 600
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and is further associated with contentment and inner
equilibrium. Present outcomes are in line with previous
research, (65) with patients having SSDs revealing decreased
negative symptoms and increased positive emotions as well as
improved overall recovery. The main mechanism behind this
effect may lie in the heightened levels of acceptance for psychotic
experience and oneself. In another study, it was shown that
mindfulness of positive symptoms was acting as a mediator
between self-compassion and positive symptom severity and
was negatively correlated with psychotic distress (108). Other
studies demonstrated a clinical moderating effect of mindfulness
for psychosis outcomes and self-compassion, indicating a
synergistic relationship between the constructs (56). Similar
associations between these factors have been shown in MDE,
hinting at a transdiagnostic understanding of mindfulness (109).
Moreover, participants described heightened feelings of
authenticity, benevolence, and empathy towards themselves as
well as to others as displayed in subcategory 2.1 (Emotions).
These findings show that there is a distinct connection between
mindfulness, compassion, and symptom outcome, even though
the direction and interrelation between these factors have yet to
be adequately studied. Future studies might examine this
relationship more closely as both constructs, mindfulness, and
compassion, possibly act as mediators regarding emotions
and mindfulness.
As a second factor, participants named effects on cognition,
which are exhibited by increased cognition, self-awareness, and
empowerment through the practice of mindfulness. Some
patients displayed increased levels of cognitive processes, such
as concentration, as well as metacognitive insights into their self-
concepts, as illustrated in subcategory 2.2 (Cognition). Among
the first to address this, Tabak and Granholm (110) found
supporting evidence concerning mindfulness effects on
cognition as well. In their study, the authors revealed that in
MBI, participants with psychosis showed significant
improvements in processing speed and working memory, as
well as increased attention/vigilance, verbal- and visual learning,
which are most frequently impaired in patients with SSDs (111).
Impaired cognition constitutes a major burden for patients with
SSDs, and current treatment choices are insufficient. Larger
controlled trials with extended mindfulness practices, similar
to MBCT in MDE, may, in the future, broaden our currently
limited knowledge regarding mindfulness and its effects on
cognitive processes in SSDs. Besides improved awareness of
cognitive functioning, participants in the present study
highlighted increased self-conceptions and self-confidence after
MBIs. Research amongst patients with MDE has shown that low
metacognition is defined by an incapability to distinguish the self
from negative thoughts, emotions, and sensations (96). Hence,
the self is occupied with negative mental phenomena inhibiting
the perception of a wider context of self. Relating and responding
mindfully to symptoms allows for a detachment from these
negative mental phenomena, alleviating distressing experiences
and thus enabling more imagination, self-acceptance, andFrontiers in Psychiatry | www.frontiersin.org 11creativity in patients with SSDs as depicted in subcategory
2.2 (Cognition).
As a last factor illustrating the effects of MBI, participants
described frequent symptom changes during and after sessions. In
the present study, participants stated improvements on anxiety
and depression levels, positive- and negative symptoms, as well
as overall well-being as depicted in subcategory 2.3 (Symptom
Changes). According to participants' responses, these changes
seem to be influenced by detachment, defusion, and acceptance
process, which primarily indicate increased psychological
flexibility. These results are in line with a handful of
randomized controlled trials (RCTs) exhibiting the
effectiveness of MBIs for in- and outpatients with SSDs on a
broad range of symptom representations, including positive and
negative symptoms, depression, anxiety, and disturbances in
cognition (56, 57, 77, 110). Moreover, multiple trials have
demonstrated increased scores for social functioning and
quality of life after MBIs (56). Possible reasons might be that
MBIs can successfully be applied in group settings, are less time-
consuming since treatment effects have been detected already
after 6-10 sessions, giving solid ground for the in-patient
implementation (74–76), and also participants show higher
commitment when compared to CBT-based approaches.
Furthermore, the present outcomes build on previous
research (58, 59, 61) by contradicting the widespread
assumption and myth that MBIs could lead to the
deterioration of psychotic symptoms. For the current study,
none of the 27 in-patients experienced a deterioration of
symptoms or showed any adverse effects. Thus, careful
adaptions of MBIs concerning the targeted population, assured
by psychometric pre-tests, proved to be explicitly fruitful and
beneficial (112), demonstrating MBIs safety and applicability in
the implementation for in-patients with SSDs. In a next step,
future research should aim to conduct RCTs assessing its
effectiveness to active and passive control conditions and
broaden the current understanding of underlying process
variables that enhance the treatment outcome.
Perception of Context and Transfer of
Therapy to Everyday Life
The main findings within the functional domain were associated
with the perception of context and transfer to everyday life, which
are described as characteristics of the framework concept of the
MBGT. For the perception of context category, participants'
responses seem to be in line with previous research stating that
explicit adaptations in the implementation process for SSDs are
required in order to facilitate the core elements and effects of
MBIs. Participants deliberately reported that constant verbal
instructions, as well as the sound of the singing bowl before
and after each exercise, gave room for the internal inquiry
process. Both context variables endorsed mindful awareness by
giving anchor stimulus to direct attention to the present
moment. Besides surrounding sounds and the therapist,
participants named the short session, as well as the group
inquiry process at the end of each exercise as fruitful andJune 2020 | Volume 11 | Article 600
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been reported in current literature, where the utilization of short
duration guided mediations (< 15 min), avoidance of prolonged
periods of silence, and continuous instructions in basic
anchoring techniques, small group sizes, and simplification of
exercises have been primarily recommended (62, 102) to mitigate
the risk of symptom deterioration. Furthermore, a simple, not
too abstract metaphoric language seems to be useful to avoid
misunderstanding, (113) while enabling enough room after each
exercise within the inquiry process. Conducting sessions in a
group format provided an efficient way to provide MBIs to a
higher number of in-patients while parallelly promoting room
for social cohesion, inclusion, participation, and exchange of
experiences. Recent research already demonstrated that
mindfulness could increase empathy, social integration, and
contact, while reducing loneliness (114, 115), altogether
building the foundation of resonance with the environment.
Through the assessment of qualitative interviews, participants
described that the group format supported mindful activities,
such as taking a mindful walk in a park nearby or mindful eating
together, which in turn helped to overcome personal and social
barriers. MBIs seem to be explicitly promising in the treatment of
negative symptoms such as blunted affect, alogia, anhedonia, or
asociality. However, future research is needed to examine the
association between perception of context factors, the
implementation, and the underlying efficacy of mindfulness.
As the last domain, the transfer to the everyday life of
mindfulness has been named by the participants. Generally, most
participants reported the wish to be able to transfer the exercises
into their everyday life. During their in-patient stay, several patients
started to cultivate mindfulness into their daily routine by taking
mindful walks or eatingmindfully with other in-patients as depicted
in subcategory 3. These steps enabled processes of self-efficacy and
empowerment, which is highlighted in subcategory 4, indicating
that even short daily exercises, such as counting the breath or taking
showers mindfully resulted in symptom decline. In this category,
other participants emphasized the utility, simplicity, and
practicability of MBIs, especially in comparison to other
interventions such as Progressive Muscle Relaxation (PMR).
Interestingly, only a minor number of participants had heard
about mindfulness previously; however, no one had any personal
experiences beforehand, indicating that a potentially valuable and
effective intervention had not been implemented in the treatment of
SSDs. The reasons may lay in the persistent myth that mindfulness
might lead to an exacerbation of symptoms, even though the
present study outcomes, as well as the current literature,
demonstrate that MBIs are safe, applicable, well-tolerated, and
lead to subjective symptoms reduction and increased well-being
even after a few sessions conducted (54, 55, 74).
Limitations
Whereas the present study aimed to explore a relatively
unnoticed research field, some limitations should be taken into
account. As patients with SSDs can have a high level of mistrust
and paranoia as symptoms of the disorder, the use of digital
recording media was omitted. Accordingly, only verbatimFrontiers in Psychiatry | www.frontiersin.org 12transcripts were made during the interviews. Furthermore,
although initial evidence exists for the applicability and
feasibility of MBIs in patients with severe positive symptoms,
this study aimed to investigate their applicability in the context of
in-patients who displayed residual symptoms with chronic
symptom representation and primarily pronounced negative-
and moderate psychotic symptoms. Also, due to the nature of
this study, applicability was assessed in a limited setting.
Therefore, to test for broader applicability, future studies
should aim to investigate the potential applicability, feasibility,
and acceptability in RCTs in different hospital settings. As this
study did not aim to investigate long term effects of MBIs for
SSDs, RCTs with pre-, post-, and follow-up measurements
should be carried out. Moreover, future research will need
control conditions to clearly differentiate outcomes. Based on
the current design, it might be that personal accounts of
participants before the intervention could have influenced the
present results, which cannot be solely attributed to MBI.
Therefore, upcoming trials should systematically examine the
indication, effectiveness as well as possible adverse- and side
effects of mindfulness for this population. Lastly, other factors
influencing meaningful communication during the interviews
might include florid psychotic symptoms leading to poor insight
and communication. Furthermore, the side-effects of
antipsychotic medication such as drowsiness cannot be ruled
out. To address these issues, future trials should carefully
monitor the medication regime and include less acute patients
from outpatient facilities to allow generalizability of the results.CONCLUSION
The current study represents the first research on participant
responses to MBI for in-patients with SSDs in a German
psychiatric hospital setting. In order to capture the novelty of
such an intervention, a qualitative approach was chosen, which
allowed for in-depth exploration of participant experiences,
perceptions, and responses, allowing for the exploration of
possible mechanisms and processes. Particular chosen
adaptations could confirm the initial applicability of the
intervention for in-patients with SSDs. Based on the analysis of
the in-patients' experiences, there is evidence that in-patients
with SSDs display responses to the interventions which are
embedded in the theoretical models of mindfulness.
Importantly, participants stated that they experienced no signs
of exacerbation or decompensation of psychotic symptoms after
MBIs. Overall, participants reported positive emotional and
metacognitive effects, changes in symptoms, and learned how
to transfer these into their daily life practice.DATA AVAILABILITY STATEMENT
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